1.71

2.84% -0.05

After Hours: 1.71

Accelerate Diagnostics Inc (AXDX)

Overview News Price History Financials Why AXDX Down? Discussions Forecast Stock Split

Accelerate Diagnostics Inc stock is traded at $1.71, with a volume of 118.39K. It is down -2.84% in the last 24 hours and down -14.44% over the past month. Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Previous Close:

$1.76

Open:

$1.79

24h Volume:

118.39K

Relative Volume:

2.20

Market Cap:

$40.49M

Revenue:

$12.00M

Net Income/Loss:

$-63.23M

P/E Ratio:

-0.2173

EPS:

-7.87

Net Cash Flow:

$-43.02M

1W Performance:

+11.76%

1M Performance:

-14.44%

6M Performance:

+72.73%

1Y Performance:

-70.26%

1-Day Range:

$1.61

$1.8146

1-Week Range:

$1.51

$1.8146

52-Week Range:

$0.73

$7.00

Accelerate Diagnostics Inc Stock (AXDX) Company Profile

Name

Accelerate Diagnostics Inc

Sector

Healthcare (1190)

Industry

Medical Devices (154)

Phone

303-863-8088

Address

3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ

Employee

134

Twitter

@AXDXNews

Next Earnings Date

2024-08-15

Latest SEC Filings

AXDX's Discussions on Twitter

Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-09-22	Downgrade	Craig Hallum	Buy → Hold
Oct-08-20	Initiated	BTIG Research	Neutral
Aug-07-20	Upgrade	Craig Hallum	Hold → Buy
Sep-27-19	Downgrade	JP Morgan	Neutral → Underweight
Nov-07-18	Downgrade	JP Morgan	Overweight → Neutral
May-24-18	Initiated	Craig Hallum	Hold
Dec-13-17	Downgrade	BTIG Research	Buy → Neutral
Jul-12-17	Resumed	BTIG Research	Buy
Mar-24-16	Initiated	JP Morgan	Overweight
Dec-16-15	Initiated	Piper Jaffray	Overweight

View All

Accelerate Diagnostics Inc Stock (AXDX) Latest News

09:15 AM

Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - StockTitan

09:15 AM

Sep 28, 2024

Short Interest in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Drops By 12.6% - Defense World

Sep 28, 2024

Sep 27, 2024

StockNews.com Initiates Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World

Sep 27, 2024

Sep 19, 2024

PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics - Yahoo Finance

Sep 19, 2024

Accelerate Diagnostics (NASDAQ:AXDX) Stock Crosses Above 200 Day Moving Average of $1.21 - Defense World

Sep 19, 2024

Accelerate Diagnostics (NASDAQ:AXDX) Research Coverage Started at StockNews.com - Defense World

Sep 19, 2024

Sep 17, 2024

Veterinary Antimicrobial Susceptibility Testing Market: In-depth Analysis Of Market Trends, Technological A... - WhaTech

Sep 17, 2024

Blood Screening Market Advancements Highlighted by Size, Share, Growth Analysis, Business Insights And Fore... - WhaTech

Sep 17, 2024

Sep 14, 2024

North America Antibiotic Sensitivity Testing Market By Application - Third Eye News

Sep 14, 2024

Sep 13, 2024

RenovaroCube to Present Cutting-Edge Cancer Diagnostics - GlobeNewswire

Sep 13, 2024

Sep 11, 2024

Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World

Sep 11, 2024

Sep 09, 2024

Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine - Business Wire

Sep 09, 2024

Chlamydia Infection Diagnostics And Therapeutics Global Market 2024Latest Trends, Technological Advancem... - WhaTech

Sep 09, 2024

Sep 08, 2024

Blood Culture Tests Market 2024: Pioneering Innovations in Diagnostic Healthcare As Discussed In New Market... - WhaTech Technology and Markets News

Sep 08, 2024

Sep 04, 2024

New Release of Ibex Medical Analytics AI-powered Platform to Accelerate Advancements in Cancer Diagnostics - Business Wire

Sep 04, 2024

In Vitro Diagnostics Market Trends 2024-2033: Overview, Share, Demand, and Outlook - WhaTech

Sep 04, 2024

Sep 03, 2024

Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated by Analysts at StockNews.com - Defense World

Sep 03, 2024

Sep 02, 2024

Emerging Trends and Opportunities in the Antimicrobial Susceptibility Testing Market - openPR

Sep 02, 2024

Aug 26, 2024

Accelerate Diagnostics regains Nasdaq compliance - Investing.com

Aug 26, 2024

Aug 20, 2024

Sepsis Diagnostics Market to Surge at 8.5% CAGR Through 2032Market.us Media - Market.us Media - United States Market News

Aug 20, 2024

Aug 14, 2024

Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results - Longview News-Journal

Aug 14, 2024